— Invitae will continue to invest in its precision oncology focused lab developed test (LDT) offerings — — The transaction contributes to Invitae's cash runway and includes a strategic supply partnership to support the growth of Invitae Personalized Cancer Monitoring™ (PCM) services — SAN FRANCISCO -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced [...]

Leading vegetable breeder digitalizes agriscience R&D workflows to scale up and increase R&D efficiency Basel, Switzerland—Genedata, a globally leading provider of advanced software solutions for life science research and development, and Rijk Zwaan, a globally leading vegetable breeding company, today announced a partnership to digitalize R&D workflows and accelerate the development of new vegetable varieties. [...]

VIENNA -- Ribbon Biolabs, the DNA synthesis company, today announced the successful implementation of their innovative InfiniSynthTM platform for the automated assembly of sequence-agnostic and long DNA. Ribbon Biolabs achieved this milestone in collaboration with HighRes® Biosolutions, a leading laboratory automation technology company. The InfiniSynthTM platform enables Ribbon Biolabs to enter the market in 2023 with a highly [...]

Diepenbeek, Belgium -- FOx BIOSYSTEMS is awarded an EIC accelerator grant for their ambitious project to bring to market a combined quantification and isolation application for extracellular vesicles (EVs) unlocking their great potential in diagnostic applications. FOx BIOSYSTEMS markets a versatile device for the life science industry using fiber-optic sensor probes to measure interactions between [...]

We are excited to inform you that eralytics has been granted the patent US 11,493,417 B2 for the automated bubble detection and bubble quantification technology FillingProofTM . When measuring a liquid’s density, the U-tube’s vertical orientation minimizes the likelihood of air bubbles becoming trapped in the density cell. To ensure bubble-free filling, eralytics has developed Filling ProofTM.  This technology is [...]

We are glad to announce that Celtarys Research has reached a strategic research cooperation agreement with the European platform EU-OPENSCREEN (https://www.eu-openscreen.eu ), a not-for-profit European Research Infrastructure Consortium (ERIC) for chemical biology and early drug discovery, supporting all stages of a chemical tool development including assay adaptation, high-throughput screening, and chemical optimisation of the ‘hit’ compounds. [...]

Shimadzu Corporation (Shimadzu) has now entered into a two-year research agreement with and the Earle A. Chiles Research Institute, a division of Providence Cancer Institute (Providence) in Portland, Oregon, Japanese Foundation for Cancer Research (JFCR) in Ariake, Tokyo, one of the advanced cancer treatment hospitals and research institutions in Japan. Shimadzu and Providence have been [...]

TOKYO and BOULDER, Colo. -- SomaLogic, Inc., a leader in proteomic technology, announced today that Tokyo-based FonesLife Corporation, will be the first SomaLogic™ Certified Site in Japan. The new site will offer the 7,000-plex SomaScan® Assay in their labs and provide SomaScan data to their customers. By becoming a SomaLogic Certified Site, FonesLife can now run [...]

Key strategic appointment as the Company enters next phase of commercial growth and global expansion of its products and services.Former CEO, Dr David Hughes, appointed to Scientific Advisory Board. CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the appointment of Dr Paul Brooks, formerly the [...]

Shimadzu Corporation (Shimadzu) has now entered into a two-year research agreement with and the Earle A. Chiles Research Institute, a division of Providence Cancer Institute (Providence) in Portland, Oregon, Japanese Foundation for Cancer Research (JFCR) in Ariake, Tokyo, one of the advanced cancer treatment hospitals and research institutions in Japan. Shimadzu and Providence have been [...]